222 related articles for article (PubMed ID: 24898885)
1. A novel treatment option for MRSA pneumonia: ceftaroline fosamil-yielding new hope in the fight against a persistent infection.
Arshad S; Hartman P; Zervos MJ
Expert Rev Anti Infect Ther; 2014 Jul; 12(7):727-9. PubMed ID: 24898885
[TBL] [Abstract][Full Text] [Related]
2. Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia.
Kaye KS; Udeani G; Cole P; Friedland HD
Hosp Pract (1995); 2015; 43(3):144-9. PubMed ID: 25956849
[TBL] [Abstract][Full Text] [Related]
3. Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults.
Welte T; Kantecki M; Stone GG; Hammond J
Int J Antimicrob Agents; 2019 Oct; 54(4):410-422. PubMed ID: 31404620
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant
Torres A; Kuraieva A; Stone GG; Cillóniz C
Eur Respir Rev; 2023 Dec; 32(170):. PubMed ID: 37852658
[TBL] [Abstract][Full Text] [Related]
5. Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients.
Pasquale TR; Tan MJ; Trienski TL; File TM
J Chemother; 2015 Feb; 27(1):29-34. PubMed ID: 24621164
[TBL] [Abstract][Full Text] [Related]
6. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Jorgenson MR; DePestel DD; Carver PL
Ann Pharmacother; 2011 Nov; 45(11):1384-98. PubMed ID: 22009993
[TBL] [Abstract][Full Text] [Related]
7. [Ceftaroline fosamil in community-acquired and nosocomial pneumonia].
Calbo E; Zaragoza R
Enferm Infecc Microbiol Clin; 2014 Mar; 32 Suppl 2():38-43. PubMed ID: 24702978
[TBL] [Abstract][Full Text] [Related]
8. The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients.
Lin JC; Aung G; Thomas A; Jahng M; Johns S; Fierer J
J Infect Chemother; 2013 Feb; 19(1):42-9. PubMed ID: 22797874
[TBL] [Abstract][Full Text] [Related]
9. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy.
Ho TT; Cadena J; Childs LM; Gonzalez-Velez M; Lewis JS
J Antimicrob Chemother; 2012 May; 67(5):1267-70. PubMed ID: 22311935
[TBL] [Abstract][Full Text] [Related]
10. Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience.
Lipsky BA; Cannon CM; Ramani A; Jandourek A; Calmaggi A; Friedland HD; Goldstein EJ
Diabetes Metab Res Rev; 2015 May; 31(4):395-401. PubMed ID: 25417910
[TBL] [Abstract][Full Text] [Related]
11. Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Zasowski EJ; Trinh TD; Claeys KC; Casapao AM; Sabagha N; Lagnf AM; Klinker KP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895012
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options.
Welte T; Pletz MW
Int J Antimicrob Agents; 2010 Nov; 36(5):391-400. PubMed ID: 20724119
[TBL] [Abstract][Full Text] [Related]
13. A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone.
Cannavino CR; Nemeth A; Korczowski B; Bradley JS; O'Neal T; Jandourek A; Friedland HD; Kaplan SL
Pediatr Infect Dis J; 2016 Jul; 35(7):752-9. PubMed ID: 27093162
[TBL] [Abstract][Full Text] [Related]
14. Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.
Frampton JE
Drugs; 2013 Jul; 73(10):1067-94. PubMed ID: 23801418
[TBL] [Abstract][Full Text] [Related]
15. Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
Scott LJ
Drugs; 2016 Nov; 76(17):1659-1674. PubMed ID: 27766567
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus epidural abscess treated with ceftaroline fosamil salvage therapy.
Bucheit J; Collins R; Joshi P
Am J Health Syst Pharm; 2014 Jan; 71(2):110-3. PubMed ID: 24375602
[TBL] [Abstract][Full Text] [Related]
17. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
Biek D; Critchley IA; Riccobene TA; Thye DA
J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv9-16. PubMed ID: 21115457
[TBL] [Abstract][Full Text] [Related]
18. Use of Ceftaroline Fosamil in Osteomyelitis: CAPTURE Study Experience.
Johnson LB; Ramani A; Guervil DJ
BMC Infect Dis; 2019 Feb; 19(1):183. PubMed ID: 30791894
[TBL] [Abstract][Full Text] [Related]
19. Summary of ceftaroline fosamil clinical trial studies and clinical safety.
File TM; Wilcox MH; Stein GE
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S173-80. PubMed ID: 22903949
[TBL] [Abstract][Full Text] [Related]
20. Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Poon H; Chang MH; Fung HB
Clin Ther; 2012 Apr; 34(4):743-65. PubMed ID: 22444785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
